Profil
Dr. Greg F.
Walker is a Manager-Research & Development at Haemostatix Ltd.
Dr. Walker was previously employed as a Principal by University of Munich and a Principal by University of Vienna.
He received his doctorate degree from the University of Otago.
Anciens postes connus de Greg F. Walker
Sociétés | Poste | Fin |
---|---|---|
Ludwig-Maximilians-Universität München | Corporate Officer/Principal | 01/01/2006 |
University of Vienna | Corporate Officer/Principal | 01/01/2002 |
Haemostatix Ltd.
Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Greg F. Walker
University of Otago | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Haemostatix Ltd.
Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |